Rocket Pharmaceuticals, Inc. (RCKT)
2.655
+0.06
(+2.12%)
USD |
NASDAQ |
Jun 11, 16:00
2.655
0.00 (0.00%)
After-Hours: 19:17
Rocket Pharmaceuticals EPS Diluted (Quarterly) : -0.4244 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.4244 |
| December 31, 2025 | -0.3805 |
| September 30, 2025 | -0.4511 |
| June 30, 2025 | -0.6208 |
| March 31, 2025 | -0.5571 |
| December 31, 2024 | -0.6186 |
| September 30, 2024 | -0.7086 |
| June 30, 2024 | -0.7429 |
| March 31, 2024 | -0.6633 |
| December 31, 2023 | -0.6392 |
| September 30, 2023 | -0.7491 |
| June 30, 2023 | -0.8164 |
| March 31, 2023 | -0.7342 |
| December 31, 2022 | -0.9154 |
| September 30, 2022 | -0.8722 |
| June 30, 2022 | -0.8309 |
| March 31, 2022 | -0.6663 |
| December 31, 2021 | -0.6863 |
| September 30, 2021 | -0.7852 |
| June 30, 2021 | -0.5475 |
| March 31, 2021 | -0.6525 |
| December 31, 2020 | -1.08 |
| September 30, 2020 | -0.5269 |
| June 30, 2020 | -0.454 |
| March 31, 2020 | -0.4494 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.3878 |
| September 30, 2019 | -0.3829 |
| June 30, 2019 | -0.3792 |
| March 31, 2019 | -0.4311 |
| December 31, 2018 | -0.6553 |
| September 30, 2018 | -0.4032 |
| June 30, 2018 | -0.3993 |
| March 31, 2018 | -0.4246 |
| December 31, 2017 | -3.917 |
| September 30, 2017 | -3.957 |
| June 30, 2017 | -1.96 |
| March 31, 2017 | -1.576 |
| December 31, 2016 | -1.92 |
| September 30, 2016 | -1.64 |
| June 30, 2016 | -1.32 |
| March 31, 2016 | -1.52 |
| December 31, 2015 | -1.237 |
| September 30, 2015 | -9.92 |
| June 30, 2015 | -0.60 |
| March 31, 2015 | -0.84 |
| December 31, 2014 | -0.779 |
| September 30, 2014 | -0.8257 |
| June 30, 2014 | -0.9516 |
| March 31, 2014 | -0.7695 |
| December 31, 2013 | -0.7018 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Replimune Group, Inc. | -0.7694 |
| ProKidney Corp. | -0.1412 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.59M |
| Total Expenses (Quarterly) | 47.59M |
| Enterprise Value | 164.11M |
| Earnings Yield | -70.69% |
| Normalized Earnings Yield | -69.85 |